[1] ALIPOUR M,GHADIRI-SOUFI F,JAFARI MR.Corrigendum:effect of aminoguanidine on sciatic functional index,oxidative stress,and rate of apoptosis in an experimental rat model of ischemia-reperfusion injury[J].Can J Physiol Phalznacol,2015,93(4):309.
[2] KARABACAK M,DOGAN A,TAYYAR S,et al.Oxidative stress status increase in patients with nonischemic heart failure[J].Med Princ Pract,2014,23(6):532.
[3] 徐中,廖敏蕾,顾俊英,等.瑞舒伐他汀对介入治疗术后冠心病慢性心力衰竭的影响[J].现代中西医结合杂志,2013,22(31):3439.
[4] 吴向军,王庆元,刘海涛,等.瑞舒伐他汀强化治疗对心肌梗死病人经皮冠状动脉介入术后脂联素和脑钠肽及左心室重构的影响[J].中国医药,2014,9(1):9.
[5] 付长庚,高铸烨,王培利,等.冠心病血瘀证诊断标准研究[J].中国中西医结合杂志,2012,32(9):1285.
[6] SCHWARTZ PJ,DE FERRARI GM.Sympathetic-parasympathetic interaction in health and disease:abnormalities and relevance in heart failure[J].Heart Failure Rev,2011,16(2):101.
[7] TAKAYAMA T,HIRO T,YAMAGISHI M,et al.COSMOS Investigators.Effect of rosuvastatin on coronary atheroma in stable coronary artery disease:multicenter coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects(COSMOS)[J].Circ J,2009,73(11):2110.
[8] 祝炜,田立群,文飞,等.调脂治疗对慢性心力衰竭病人超氧化应激损伤的干预作用[J].中国医院药学杂志,2014,34(16):1395.
[9] 万玉兰,方孝俊,谭子富,等.瑞舒伐他汀钙治疗舒张性心力衰竭42例临床观察[J].中西医结合心脑血管病杂志,2013,11(6):663.
[10] HAMLIN SK,BENEDIK PS.Basic concepts of hemorheology in microvascular hemodynamics[J].Crit Care Nurs Clin North Am,2014,26(3):337.
[11] 孙喜文,邓红胜,陈炎,等.瑞舒伐他汀对慢性心力衰竭合并肾功能不全病人的疗效观察[J].中国心血管病研究,2014,12(7):647.
[12] 陈彬,刘华,吴瑞霞,等.瑞舒伐他汀对慢性心力衰竭病人心功能及hs-CRP、sCD40L的影响[J].中西医结合心脑血管病杂志,2013,11(2):135.
[13] 刘洪沛,黄涛.瑞舒伐他汀/辛伐他汀治疗慢性心力衰竭的疗效比较[J].西南国防医药,2014,24(6):601.
[14] LEE CW,KANG SJ,AHN JM,et al.Comparison of effects of atorvastatin(20 mg) versus rosuvastatin(10 mg) therapy on mild coronary atherosclerotic plaques[J].Am J Cardiol,2012,109(12):1700.
[15] 邹清梅,刘瑶,高金全,等.盐酸曲美他嗪对冠状动脉粥样硬化性心脏病心力衰竭病人疗效和对氧化应激及血液流变学的影响[J].中国医药,2015,10(8):1112.
[16] 田薇薇,余自成,干志彬,等.阿托伐他汀致肝功能异常的危险因素分析[J].中国新药与临床杂志,2015(10):807.
[17] 徐行仙,徐爱建,徐德政.阿托伐他汀与瑞舒伐他汀对冠心病病人肝功能影响的对比[J].中国药师,2015(2):255.